130 related articles for article (PubMed ID: 21933638)
1. Loss of correlation between intensities of desmoglein 2 and desmoglein 3 expression in basal cell carcinomas.
Gornowicz-Porowska J; Bowszyc-Dmochowska M; Seraszek-Jaros A; Kaczmarek E; Dmochowski M
Acta Dermatovenerol Croat; 2011; 19(3):150-5. PubMed ID: 21933638
[TBL] [Abstract][Full Text] [Related]
2. Discordant expression of desmoglein 2 and 3 at the mRNA and protein levels in nodular and superficial basal cell carcinoma revealed by immunohistochemistry and fluorescent in situ hybridization.
Pietkiewicz P; Gornowicz-Porowska J; Bowszyc-Dmochowska M; Jagielska J; Helak-Łapaj C; Kaczmarek E; Dmochowski M
Clin Exp Dermatol; 2014 Jul; 39(5):628-35. PubMed ID: 24934917
[TBL] [Abstract][Full Text] [Related]
3. Desmoglein 2 compensates for desmoglein 3 but does not control cell adhesion via regulation of p38 mitogen-activated protein kinase in keratinocytes.
Hartlieb E; Rötzer V; Radeva M; Spindler V; Waschke J
J Biol Chem; 2014 Jun; 289(24):17043-53. PubMed ID: 24782306
[TBL] [Abstract][Full Text] [Related]
4. The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium, serum, and protein kinase C.
Denning MF; Guy SG; Ellerbroek SM; Norvell SM; Kowalczyk AP; Green KJ
Exp Cell Res; 1998 Feb; 239(1):50-9. PubMed ID: 9511724
[TBL] [Abstract][Full Text] [Related]
5. Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion.
Hartlieb E; Kempf B; Partilla M; Vigh B; Spindler V; Waschke J
PLoS One; 2013; 8(1):e53739. PubMed ID: 23326495
[TBL] [Abstract][Full Text] [Related]
6. A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma.
Teh MT; Parkinson EK; Thurlow JK; Liu F; Fortune F; Wan H
J Oral Pathol Med; 2011 Jan; 40(1):67-76. PubMed ID: 20923451
[TBL] [Abstract][Full Text] [Related]
7. Expression of desmogleins 1-3 and their clinical impacts on human lung cancer.
Saaber F; Chen Y; Cui T; Yang L; Mireskandari M; Petersen I
Pathol Res Pract; 2015 Mar; 211(3):208-13. PubMed ID: 25468811
[TBL] [Abstract][Full Text] [Related]
8. Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins.
Schäfer S; Koch PJ; Franke WW
Exp Cell Res; 1994 Apr; 211(2):391-9. PubMed ID: 8143788
[TBL] [Abstract][Full Text] [Related]
9. Dsg2 Upregulation as a Rescue Mechanism in Pemphigus.
Sigmund AM; Steinert LS; Egu DT; Bayerbach FC; Waschke J; Vielmuth F
Front Immunol; 2020; 11():581370. PubMed ID: 33193387
[TBL] [Abstract][Full Text] [Related]
10. Interspecies conservation and differential expression of mouse desmoglein gene family.
Mahoney MG; Simpson A; Aho S; Uitto J; Pulkkinen L
Exp Dermatol; 2002 Apr; 11(2):115-25. PubMed ID: 11994138
[TBL] [Abstract][Full Text] [Related]
11. Hierarchical expression of desmosomal cadherins during stratified epithelial morphogenesis in the mouse.
King IA; Angst BD; Hunt DM; Kruger M; Arnemann J; Buxton RS
Differentiation; 1997 Nov; 62(2):83-96. PubMed ID: 9404003
[TBL] [Abstract][Full Text] [Related]
12. Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer.
Ramani VC; Hennings L; Haun RS
BMC Cancer; 2008 Dec; 8():373. PubMed ID: 19091121
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of desmoglein 2 and desmoglein 3 in esophageal squamous cell carcinoma.
Fang WK; Gu W; Liao LD; Chen B; Wu ZY; Wu JY; Shen J; Xu LY; Li EM
Asian Pac J Cancer Prev; 2014; 15(2):871-6. PubMed ID: 24568510
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma.
Yashiro M; Nishioka N; Hirakawa K
Eur J Cancer; 2006 Sep; 42(14):2397-403. PubMed ID: 16890424
[TBL] [Abstract][Full Text] [Related]
15. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes.
Brennan D; Hu Y; Joubeh S; Choi YW; Whitaker-Menezes D; O'Brien T; Uitto J; Rodeck U; Mahoney MG
J Cell Sci; 2007 Mar; 120(Pt 5):758-71. PubMed ID: 17284515
[TBL] [Abstract][Full Text] [Related]
16. Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma.
Ormanns S; Altendorf-Hofmann A; Jackstadt R; Horst D; Assmann G; Zhao Y; Bruns C; Kirchner T; Knösel T
Br J Cancer; 2015 Nov; 113(10):1460-6. PubMed ID: 26469831
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of Dsg2 in malignant skin carcinomas: A tissue-microarray based study.
Brennan D; Mahoney MG
Cell Adh Migr; 2009; 3(2):148-54. PubMed ID: 19458482
[TBL] [Abstract][Full Text] [Related]
18. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis.
Oktarina DA; van der Wier G; Diercks GF; Jonkman MF; Pas HH
Br J Dermatol; 2011 Sep; 165(3):552-62. PubMed ID: 21692763
[TBL] [Abstract][Full Text] [Related]
19. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis.
Brennan-Crispi DM; Hossain C; Sahu J; Brady M; Riobo NA; Mahoney MG
Oncotarget; 2015 Apr; 6(11):8593-605. PubMed ID: 25871385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
